The current RKDA market cap is 2.29M. The company's latest EPS is USD -12.5917 and P/E is -0.16.
Quarter End | Sep 2022 | Dec 2022 | Mar 2023 | Jun 2023 | Sep 2023 |
---|---|---|---|---|---|
USD ($) | USD ($) | USD ($) | USD ($) | USD ($) | |
Total Revenue | 3.02M | 1M | 1.51M | 1.39M | 1.26M |
Operating Income | -3.44M | -5.76M | -4.07M | -3.8M | -2.74M |
Net Income | -2.87M | -4.24M | -9.38M | 823k | -2.57M |
Year End December 30 2023 | 2019 | 2020 | 2021 | 2022 | 2023 |
---|---|---|---|---|---|
USD ($) | USD ($) | USD ($) | USD ($) | USD ($) | |
Total Revenue | 2.17M | 8.03M | 6.78M | 9.96M | 5.33M |
Operating Income | -19.38M | -21.59M | -35.24M | -20.34M | -13.98M |
Net Income | -28.81M | -4.66M | -14.66M | -15.38M | -13.98M |
Quarter End | Sep 2022 | Dec 2022 | Mar 2023 | Jun 2023 | Sep 2023 |
---|---|---|---|---|---|
USD ($) | USD ($) | USD ($) | USD ($) | USD ($) | |
Total Assets | 34.47M | 28.92M | 30.41M | 26.8M | 23.47M |
Total Liabilities | 9.46M | 8.02M | 13.72M | 9.07M | 8.07M |
Total Equity | 25.02M | 20.9M | 16.69M | 17.73M | 15.4M |
Year End December 30 2023 | 2019 | 2020 | 2021 | 2022 | 2023 |
---|---|---|---|---|---|
USD ($) | USD ($) | USD ($) | USD ($) | USD ($) | |
Total Assets | 32.57M | 47.35M | 43.92M | 28.92M | 19.71M |
Total Liabilities | 24.25M | 18.8M | 12.72M | 8.02M | 7M |
Total Equity | 8.33M | 28.55M | 31.2M | 20.9M | 12.7M |
Quarter End | Sep 2022 | Dec 2022 | Mar 2023 | Jun 2023 | Sep 2023 |
---|---|---|---|---|---|
USD ($) | USD ($) | USD ($) | USD ($) | USD ($) | |
Operating | -11.62M | -13.98M | -3.47M | -8.26M | -11.15M |
Investing | 1.14M | 1.42M | 315k | -4.4M | -4.4M |
Financing | 4.52M | 4.52M | 5.51M | 5.51M | 5.51M |
Year End December 30 2023 | 2019 | 2020 | 2021 | 2022 | 2023 |
---|---|---|---|---|---|
USD ($) | USD ($) | USD ($) | USD ($) | USD ($) | |
Operating | -17.2M | -30.22M | -25.87M | -13.98M | -15.29M |
Investing | -8.37M | 17.28M | 16.61M | 1.42M | -4.34M |
Financing | 21.99M | 20.56M | 21.9M | 4.52M | 5.51M |
Market Cap | 2.29M |
Price to Earnings Ratio | -0.16 |
Price to Sales Ratio | 0.43 |
Price to Cash Ratio | 0.35 |
Price to Book Ratio | 0.18 |
Dividend Yield | - |
Shares Outstanding | 1.11M |
Average Volume (1 week) | 34.11k |
Average Volume (1 Month) | 22.16k |
52 Week Change | -66.56% |
52 Week High | 7.30 |
52 Week Low | 1.8512 |
Spread (Intraday) | 0.21 (9.77%) |
Company Name | Arcadia Biosciences Inc |
Address |
1209 orange street wilmington, delaware 19801 |
Website | https://www.arcadiabio.com |
Industry | pesticides, agric chems, nec (2879) |
It looks like you are not logged in. Click the button below to log in and keep track of your recent history.